Literature DB >> 34982138

How to Use and Interpret the Results of a Platform Trial: Users' Guide to the Medical Literature.

Jay J H Park1,2, Michelle A Detry3, Srinivas Murthy4, Gordon Guyatt2, Edward J Mills2,5.   

Abstract

Platform trials are a type of randomized clinical trial that allow simultaneous comparison of multiple intervention groups against a single control group that serves as a common control based on a prespecified interim analysis plan. The platform trial design enables introduction of new interventions after the trial is initiated to evaluate multiple interventions in an ongoing manner using a single overarching protocol called a master (or core) protocol. When multiple treatment candidates are available, rapid scientific therapeutic discoveries may be made. Platform trials have important potential advantages in creating an efficient trial infrastructure that can help address critical clinical questions as the evidence evolves. Platform trials have recently been used in investigations of evolving therapies for patients with COVID-19. The purpose of this Users' Guide to the Medical Literature is to describe fundamental concepts of platform trials and master protocols and review issues in the conduct and interpretation of these studies. This Users' Guide is intended to help clinicians and readers understand articles reporting on interventions evaluated using platform trial designs.

Entities:  

Mesh:

Year:  2022        PMID: 34982138     DOI: 10.1001/jama.2021.22507

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  2 in total

Review 1.  Optimizing the Design and Analysis of Future AKI Trials.

Authors:  Matthieu Legrand; Sean M Bagshaw; Jay L Koyner; Ivonne H Schulman; Michael R Mathis; Juliane Bernholz; Steven Coca; Martin Gallagher; Stéphane Gaudry; Kathleen D Liu; Ravindra L Mehta; Romain Pirracchio; Abigail Ryan; Dominik Steubl; Norman Stockbridge; Fredrik Erlandsson; Alparslan Turan; F Perry Wilson; Alexander Zarbock; Michael P Bokoch; Jonathan D Casey; Patrick Rossignol; Michael O Harhay
Journal:  J Am Soc Nephrol       Date:  2022-07-13       Impact factor: 14.978

Review 2.  Novel Clinical Trial Designs in Neuro-Oncology.

Authors:  Anurag Saraf; Lorenzo Trippa; Rifaquat Rahman
Journal:  Neurotherapeutics       Date:  2022-08-15       Impact factor: 6.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.